Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can daily habits shield RA hearts from artery stiffness?

NCT ID NCT07774507

Knowledge-focused Sponsor: São Paulo State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This observational study looks at how physical activity, sedentary time, and sleep relate to early signs of heart and blood vessel disease in adults with rheumatoid arthritis. Participants will wear activity monitors for a week, answer health questionnaires, and undergo heart and fitness assessments, with a follow-up after 12 months. The goal is to see whether daily movement patterns are linked to arterial stiffness and other cardiovascular risk indicators, which could guide future lifestyle advice for this population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
Could inform future lifestyle recommendations to help people with rheumatoid arthritis reduce their cardiovascular risk.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to all RA patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adults with a medical diagnosis of rheumatoid arthritis. Participants will be recruited through rheumatology clinics, healthcare services, hospitals, rehabilitation centers, patient support groups, and community outreach initiatives. The recruitment strategy is intended to include individuals with diverse socioeconomic backgrounds, disease durations, and levels of disease severity, thereby enhancing the representativeness of the study population.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Medical diagnosis of rheumatoid arthritis. * Age between 18 and 65 years. * Provide written informed consent. * Independence in daily living activities defined as a Katz Index score of 5 or 6 points. Exclusion Criteria: * Acute infectious disease at the time of assessment. * Pregnancy or breastfeeding. * Cognitive impairment identified by the Mini-Mental State Examination according to established cutoff values. * History of cardiovascular disease, including coronary artery disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, or pulmonary embolism. * Use of uncontrolled vasoactive medication. * Inability to comply with accelerometer wear requirements. * Inability to complete study questionnaires or physical assessments. * Invalid accelerometer data according to the study wear-time criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 24-hour movement guidelines are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity rheumatoid arthritis Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

24-hour movement guidelines Cardiovascular risk assessment Rheumatoid arthritis (RA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sao Paulo State University

    RECRUITING

    Presidente Prudente, São Paulo, 19060900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.